These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1689662)

  • 21. Differential expression of cell activation markers after stimulation of resting human B lymphocytes.
    Kehrl JH; Muraguchi A; Fauci AS
    J Immunol; 1984 Jun; 132(6):2857-61. PubMed ID: 6427329
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential expression of a surface antigen recognized by a monoclonal antibody, J11d, on unprimed and primed B cells.
    Pillai PS; Reynolds SD; Chace JH; Scott DW
    J Immunol; 1986 Aug; 137(3):791-7. PubMed ID: 3487587
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Studies of in vitro activation and differentiation of human B lymphocytes. I. Phenotypic and functional characterization of the B cell population responding to anti-Ig antibody.
    Boyd AW; Anderson KC; Freedman AS; Fisher DC; Slaughenhoupt B; Schlossman SF; Nadler LM
    J Immunol; 1985 Mar; 134(3):1516-23. PubMed ID: 3871451
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Soluble, but not immobilized, anti-IgM antibody inhibits post-activation events leading to T-cell-dependent B-cell differentiation.
    Zamorano J; Rivas D; Gayo A; Mozo L; Gutiérrez C
    Immunology; 1995 Jun; 85(2):241-7. PubMed ID: 7642212
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factors modifying survival pathways of germinal center B cells. Glucocorticoids and transforming growth factor-beta, but not cyclosporin A or anti-CD19, block surface immunoglobulin-mediated rescue from apoptosis.
    Holder MJ; Knox K; Gordon J
    Eur J Immunol; 1992 Oct; 22(10):2725-8. PubMed ID: 1382997
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The synergistic effects of anti-IgM and monoclonal anti-Ia antibodies in induction of murine B lymphocyte activation.
    Baluyut AR; Subbarao B
    J Mol Cell Immunol; 1988; 4(1):45-57. PubMed ID: 3266924
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel pathway of human B cell activation initiated by CK226 surface antigen.
    Poggi A; Maggi E; Biagiotti R; Giudizi MG; Almerigogna F; Pella N; Caligaris-Cappio F; Romagnani S; Moretta L
    Eur J Immunol; 1990 May; 20(5):1161-5. PubMed ID: 2141569
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transmembrane signals generated through MHC class II, CD19, CD20, CD39, and CD40 antigens induce LFA-1-dependent and independent adhesion in human B cells through a tyrosine kinase-dependent pathway.
    Kansas GS; Tedder TF
    J Immunol; 1991 Dec; 147(12):4094-102. PubMed ID: 1721639
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytolysis of leukemic B-cells by T-cells activated via two bispecific antibodies.
    Bohlen H; Manzke O; Patel B; Moldenhauer G; Dörken B; von Fliedner V; Diehl V; Tesch H
    Cancer Res; 1993 Sep; 53(18):4310-4. PubMed ID: 7689932
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD77: an antigen of germinal center B cells entering apoptosis.
    Mangeney M; Richard Y; Coulaud D; Tursz T; Wiels J
    Eur J Immunol; 1991 May; 21(5):1131-40. PubMed ID: 1709864
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impairment of T-cell-dependent B-cell responses and B-1 cell development in CD19-deficient mice.
    Rickert RC; Rajewsky K; Roes J
    Nature; 1995 Jul; 376(6538):352-5. PubMed ID: 7543183
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The B cell surface molecule B1 is functionally linked with B cell activation and differentiation.
    Tedder TF; Boyd AW; Freedman AS; Nadler LM; Schlossman SF
    J Immunol; 1985 Aug; 135(2):973-9. PubMed ID: 3925015
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Quantitative flowcytometric analysis of B cell surface antigens in patients with autoimmune diseases].
    Oooto Y; Ikemoto T; Nakagawa T; Shimizu A
    Rinsho Byori; 1995 Apr; 43(4):381-4. PubMed ID: 7537832
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulatory role of CD19 molecules in B-cell activation and differentiation.
    de Rie MA; Schumacher TN; van Schijndel GM; van Lier RA; Miedema F
    Cell Immunol; 1989 Feb; 118(2):368-81. PubMed ID: 2463100
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human B cell differentiation. IV. Effect of monoclonal anti-immunoglobulin M and D antibodies on B cell proliferation and differentiation induced by T cell factors.
    Kuritani T; Cooper MD
    J Immunol; 1983 Sep; 131(3):1306-11. PubMed ID: 6224857
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of ricin A chain-containing immunotoxins directed against CD19 and CD22 antigens on normal and malignant human B-cells as potential reagents for in vivo therapy.
    Ghetie MA; May RD; Till M; Uhr JW; Ghetie V; Knowles PP; Relf M; Brown A; Wallace PM; Janossy G
    Cancer Res; 1988 May; 48(9):2610-7. PubMed ID: 2451562
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional evaluation of CD19- and CD22-negative variants of B-lymphoid cell lines.
    Kiesel S; Pezzutto A; Haas R; Moldenhauer G; Dörken B
    Immunology; 1988 Jul; 64(3):445-50. PubMed ID: 3261711
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The CD19/CD21 signal transducing complex of human B lymphocytes includes the target of antiproliferative antibody-1 and Leu-13 molecules.
    Bradbury LE; Kansas GS; Levy S; Evans RL; Tedder TF
    J Immunol; 1992 Nov; 149(9):2841-50. PubMed ID: 1383329
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vivo generation and function of B cells in the presence of a monoclonal anti-IgM antibody: implications for B cell tolerance.
    Gause A; Yoshida N; Kappen C; Rajewsky K
    Eur J Immunol; 1987 Jul; 17(7):981-90. PubMed ID: 3497044
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Isolation and functional analysis of human B cell populations. I. Characterization of the B1+B2+ and B1+B2- subsets.
    Anderson KC; Boyd AW; Fisher DC; Slaughenhoupt B; Groopman JE; O'Hara CJ; Daley JF; Schlossman SF; Nadler LM
    J Immunol; 1985 Feb; 134(2):820-7. PubMed ID: 3917476
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.